Myopia Management
NEW: ZEISS MyoActive Myopia Management Lenses
Available at Matador Eyeworks in Milton, Ontario as of October 1, 2026!
Introducing the newest premium myopia management lens from ZEISS.
We’re pleased to announce that ZEISS MyoActive lenses are now available at Matador Eyeworks in Milton!
Myopia, also known as nearsightedness, causes distant objects to appear blurry and can progress as children grow. ZEISS MyoActive lenses are designed to provide clear vision while helping slow the progression of childhood myopia.
Featuring innovative M.O.V.E. Technology, ZEISS MyoActive introduces a new approach to myopia management, using multiple levels of myopic defocus designed to create dynamic retinal signals.
ZEISS MyoActive: Promising Clinical Results
ZEISS describes MyoActive as its most effective myopia management solution to date, based on its clinical results. The one-year findings in children aged 7 to 13 include several encouraging results.
No progression of clinical relevance, on average*
ZEISS reports that average myopia progression remained below 0.25 dioptres, which it defines as “no progression of clinical relevance.”
73% average slowing of myopia progression
At 12 months, ZEISS MyoActive demonstrated an average of 0.60 dioptres less myopia progression compared with standard single-vision prescription lenses.
0.22 mm less axial elongation
Axial elongation refers to the lengthening of the eye. ZEISS reported an average of 0.22 mm less axial elongation compared with standard single-vision prescription lenses.
100% emmetropic-like eye growth
ZEISS reports that all children in the MyoActive study group showed eye growth described as emmetropic-like, meaning a pattern of growth associated with eyes without myopia.
98% adapted within one week
Almost all children in the study became fully accustomed to ZEISS MyoActive lenses within one week. The reported wearing time was at least 12 hours per day.
Clear vision for everyday life
At dispensing, 93% of children rated their distance vision as very good, while 93% rated their near vision as good or very good.
ZEISS also reported consistent efficacy between the first six months and the second six months of the study.
Clinical data: ZEISS data on file, study NCT06563700. Two-year prospective, multicentre, double-blind, randomised controlled trial comparing ZEISS MyoActive lenses (n=56) with standard single-vision prescription lenses (n=56) in children aged 7–13. Results reported at one year, as of July 2026. “No progression of clinical relevance” is defined by ZEISS as mean progression of less than 0.25 D. Vision ratings were recorded at dispensing. Individual results may vary.
Is ZEISS MyoActive Right for Your Child?
Every child’s vision is different, and the right approach to myopia management depends on their individual needs.
Alongside ZEISS MyoActive, Matador Eyeworks offers other myopia management lens options, including ZEISS MyoCare and Hoya MiYOSMART.
We’d be happy to help you learn more about these options and explore the possibilities for your child.
Interested in ZEISS MyoActive for your child?
Visit Matador Eyeworks in Milton to learn more about ZEISS MyoActive and explore the myopia management lens options available for your family. Mark and Zeena would be happy to help you learn more!
ZEISS MyoCare lenses
A better outlook on life.
The first age-related myopia management portfolio from ZEISS with lens designs aimed to slow down the progression of myopia. MyoCare is backed by ZEISS innovation and more than a decade of experience in developing lenses to manage myopia progression.

The ZEISS MyoCare designs show an average emmetropic progression ratio for axial length of up to 86% for children aged 10-12 years and 63% for children aged 7-9 years.4


A new lens design.
Creating simultaneous competing defocus.
The latest lens from ZEISS designed to manage progressive myopia in children, is built on more than a decade of ZEISS innovation and experience in myopia management, in collaboration with optical experts such as material and vision scientists, eye care practitioners and academics. The design of ZEISS MyoCare lenses incorporates scientific concepts from proven scientific research, evidence-based learnings and effective treatments.
ZEISS C.A.R.E.® technology
(Cylindrical Annular Refractive Elements)
As children grow, their eyes become longer. Myopia develops if eye elongation is more than it should be at a given age. Myopia can be managed by slowing down this excessive lengthening of the eye. MyoCare lenses feature special ring-shaped optical structures on the lens surface. These C.A.R.E.® structures trigger a signal in the back of the eye to slow down excessive growth of the eye and ultimately myopia progression.
ZEISS ClearFocus design
The back surface of the lens is optimised to give your child clear and comfortable vision through the lens, in all viewing directions. ZEISS ClearFocus technology also minimises any blur that can contribute to eye elongation.
ZEISS DuraVision coating
An anti-reflective coating with scratch resistant properties that is applied to the lens surface to make it more robust – perfect for active young children.
ZEISS UVProtect technology
Full UV protection, which means your child’s eyes are protected when they’re playing outside.


ZEISS ClearFocus design.
Addressing the constant movement of the eyes.
Spectacle lenses must consider the moving eye behind the lens to ensure that the intended correction and myopic defocus is maintained for all gaze angles. With the ZEISS ClearFocus design, both the optimal refractive correction according to the patient’s refractive demands and the intended myopic defocus are maintained for all gaze directions. This is important not only for distinct viewing behaviours through the central clear zone when pursuing a focused task, but also for unintended gazes and saccades to the lens periphery.
In addition to that, the ZEISS ClearFocus design effectively minimises the induction of hyperopic defocus as opposed to typical spherical single vision lenses.
A new approach to measure effectiveness.
Emmetropic progression ratio.
Each myopia progression management intervention has its own advantages and disadvantages, however each option pursues a common target:
To slow down myopia progression.
Developmental milestones offer important insights into a child’s developmental health. Reaching specific milestones at a given age shows a child is developing as expected. A comparison between the normal physiological growth and the patient’s current growth is needed to observe whether there is some type of non-physiological deviation present.
The ZEISS MyoCare designs show an average emmetropic progression ratio for axial length of up to 86% for children aged 10-12 years and 63% for children aged 7-9 years.4

ZEISS MyoCare Lenses
Special myopia management eyeglass lenses from ZEISS are a convenient method for treating progressive myopia in children. These lenses are designed for treating the progression of myopia and are probably the most comfortable solution for a young patient.
Since lack of sunlight, more work in the near vision range and too much time indoors are also crucial factors in the emergence of myopia in children, it is recommended that kids spend more time outdoors – in addition to treatment with eyeglass lenses. Studies have shown that myopia is less common or progresses less quickly in children who are frequently outside. It has been proven that children enjoy better results by combining myopia management treatments with a healthy lifestyle – including breaks from digital devices like smartphones and tablets!
Please note: spending time outside in the fresh air and getting regular exercise, such as by playing sports, are part of a child’s healthy development. In order to protect children’s eyes from the damage caused by excessive UV radiation, special glasses for myopia in children must have a UV suitable filter. This is not just true for sunglasses, but also for children’s glasses with clear lenses.
ZEISS eyeglass lenses for treating myopia in children offer comprehensive UV protection: like sunglasses, they filter out UV radiation completely and protect not only the wearer’s eyes, but also the surrounding skin and tissue of the periorbital structures.
We also provide Hoya Miyosmart Myopia Management Lenses

